Skip to search formSkip to main contentSkip to account menu

Xeloda

Known as: Xeloda® 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
TPS819Background: Colorectal cancer (CRC) is one of the most commonly diagnosed solid tumors worldwide. Current therapies for the… 
2016
2016
PURPOSE The purpose of this study was to evaluate the efficacy and toxicity of a third-generation chemotherapy regimen in the… 
2015
2015
OBJECTIVE To explore the clinical efficacy and toxic and side effects of recombinant human endostatin (rh- endostatin/endostar… 
Review
2014
Review
2014
The study aimed to compare the 2 main types of insurance used by colorectal cancer (CRC) patients in a university hospital in… 
Review
2013
Review
2013
Case report of a translocation : t(2;11)(q31;p15) in therapy related myeloid neoplasm: case report and review of literature. 
Review
2007
Review
2007
Pancreatic neuroendocrine tumors (NETs) consist of a wide group of neoplasms with diVerent biologic and clinical characteristics… 
Review
2005
Review
2005
The Oncologist 2005;10:320–322 www.TheOncologist.com Correspondence: Herbert Hurwitz, M.D., Room 3802, Duke University Medical… 
2003
2003
The effectiveness and tolerability of xeloda (capecitabine), a tumor-reactivated oral fluoropyrimidine, alone were investigated… 
2003
2003
OBJECTIVE To evaluate the effect of combined preoperative xeloda and pelvic radiotherapy on locally advanced lower rectal cancer… 
2002
2002
OBJECTIVE To evaluate the response rate and adverse reactions of xeloda, an analogue of 5-fluorouracil, in the treatment of…